Vaira, Valentina <br/><br/>
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  Mar 2015 
 - 1077-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/liv.12636  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Hepatocellular--drug therapy<br/>Case-Control Studies<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>MicroRNAs--metabolism<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Sorafenib